Lemborexant, a small molecule compound that obstructs orexin-signaling by binding to orexin receptors, showed many insomnia-related benefits, according to a ...
Updated: 07/05/2019 08:45A
Researchers estimate that between one-third and one-half of all marketed drugs act by binding to GPCRs, according to Nature, and that has made them a big target for drug developers although many GPCRs are “orphan,” meaning their precise roles and ...
Updated: 12/04/2018 09:39A